Do Big Money Love Zoetis Inc (NYSE:ZTS), Sentiment at 1.12

June 27, 2018 - By Theresa McIntyre

Zoetis Inc. (NYSE:ZTS) Corporate Logo

“Big money” Positions

“Big money sentiment for Zoetis Inc (NYSE:ZTS) in Q1 2018 decreased to 1.12, SEC filings reveal. That’s down -0.01, from 2017Q4’s 1.13. 338 hedge funds increased and opened new holdings, while 303 sold and reduced holdings in Zoetis Inc so the sentiment dived. These funds own 419.33 million shares, that’s down from 429.52 million shares in 2017Q4. Funds holding Zoetis Inc in top 10 increased from 10 to 20 for an increase of 10. In total 33 funds closed positions, 270 reduced and 239 increased. Also 99 funds bought new Zoetis Inc stakes.

Biggest Zoetis Inc Investors

As of Q1 2018 Blackhill Capital Inc has 5.34% invested in Zoetis Inc. Zoetis Inc’s shareholder Polen Capital Management Llc owns 8.94 million shares as of Q1 2018. Dsm Capital Partners Llc reported 4.02 million shares. The New York-based fund Sandhill Capital Partners Llc have invested about 4.16% of the investment professional’s stock portfolio in Zoetis Inc. The New York-based fund Cantillon Capital Management Llc looks positive on Zoetis Inc, having 4.13 million shares.

Zoetis Inc. engages in the discovery, development, manufacture, and commercialization of animal health medicines and vaccines for livestock and companion animals in the United States and internationally.The firm is valued at $40.71 billion. It offers anti-infectives that prevent, kill, or slow the growth of bacteria, fungi, or protozoa; vaccines, which are biological preparations to prevent diseases of the respiratory, gastrointestinal, and reproductive tracts or induce a specific immune response; and parasiticides that prevent or eliminate external and internal parasites, such as fleas, ticks, and worms.The P/E ratio is 42.3. The firm also provides medicated feed additives that offer medicines to livestock; and other pharmaceutical products, including pain and sedation, oncology, antiemetic, allergy and dermatology, and reproductive products.

ZTS is hitting $84.13 during the last trading session, after increased 0.14%.Zoetis Inc. has volume of 1.01M shares. Since June 27, 2017 ZTS has risen 33.70% and is uptrending. ZTS outperformed by 21.13% the S&P 500.

Zoetis Inc. (NYSE:ZTS)’s quarterly earnings will be reported on August, 14., according to Zacks. Analysts predict 33.96 % diference or $0.71 from the $0.53 EPS from 2017. The profit will be $343.55 million for ZTS if $0.71 earnings per share becomes true. Wall Street now sees -5.33 % negative EPS growth despite Zoetis Inc. previous quarter’s EPS of $0.75.

Sector Pension Invest Board has invested 0.08% in Zoetis Inc. (NYSE:ZTS). Jefferies Grp Incorporated Ltd Llc accumulated 47,207 shs or 0.02% of the stock. New Hampshire-based Lumbard & Kellner Ltd Liability Corporation has invested 2.51% in Zoetis Inc. (NYSE:ZTS). Copeland Capital Ltd Company has 153,005 shs. Btc Capital Mngmt accumulated 46,584 shs. Swiss Commercial Bank has invested 0.16% in Zoetis Inc. (NYSE:ZTS). Highbridge Capital Management Ltd Liability accumulated 6,473 shs or 0.01% of the stock. 262,674 are owned by Toronto Dominion State Bank. Putnam Investments Ltd has invested 0.02% in Zoetis Inc. (NYSE:ZTS). 670,485 were reported by Kayne Anderson Rudnick Lc. Utah Retirement has 91,600 shs. Gsa Capital Prtnrs Ltd Liability Partnership stated it has 3,627 shs. Royal Fincl Bank Of Canada stated it has 0.12% in Zoetis Inc. (NYSE:ZTS). North Carolina-based Willingdon Wealth Mgmt has invested 0.01% in Zoetis Inc. (NYSE:ZTS). Wellington Limited Liability Partnership holds 0% in Zoetis Inc. (NYSE:ZTS) or 206,763 shs.

Zoetis Inc. had 5 insider sales and 0 insider buys since February 21, 2018. This’s net activity of $7.23 million. The insider Chen Heidi C. sold 7,383 shs worth $625,414. The insider Lagano Roxanne sold 35,663 shs worth $2.89M. PECK KRISTIN C had sold 32,000 shs worth $2.60 million on Wednesday, February 21.

Zoetis Inc. (NYSE:ZTS) Ratings Coverage

In total 11 analysts cover Zoetis (NYSE:ZTS). “Buy” rating has 7, “Sell” are 0, while 4 are “Hold”. 64% are bullish. 15 are the (NYSE:ZTS)’s analyst reports since January 2, 2018 according to StockzIntelligence Inc. On Friday, February 16 the stock of Zoetis Inc. (NYSE:ZTS) has “Hold” rating given by Deutsche Bank. On Wednesday, April 25 the firm earned “Buy” rating by Craig Hallum. On Monday, February 26 the rating was maintained by Jefferies with “Buy”. On Monday, March 19 Morgan Stanley downgraded Zoetis Inc. (NYSE:ZTS) to “Equal-Weight” rating. On Thursday, April 5 the firm has “Outperform” rating by Credit Suisse given. The company rating was maintained by Stifel Nicolaus on Thursday, February 15. On Thursday, January 4 the stock of Zoetis Inc. (NYSE:ZTS) has “Buy” rating given by Citigroup. On Friday, April 13 the stock of Zoetis Inc. (NYSE:ZTS) has “Buy” rating given by Jefferies. On Tuesday, January 16 the rating was maintained by Stifel Nicolaus with “Buy”. On Tuesday, January 2 the stock of Zoetis Inc. (NYSE:ZTS) earned “Buy” rating by Craig Hallum.

There’s a substantial Zoetis Inc. (NYSE:ZTS) news posted by Globenewswire.com. It’s an article titled: “Recent Analysis Shows CIT Group, Zoetis, Deere, Hecla Mining, iRobot, and First BanCorp Market Influences …” on June 26, 2018.

Zoetis Inc. (NYSE:ZTS) Institutional Investors Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.